MoneyWorks4Me

Sigachi Industries - Quaterly Results

18 Jan 2025 Evaluate
The sales for the December 2024 quarter moved up 36.76% to Rs. 1050.76 millions as compared to Rs. 768.33 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -10.17% to Rs. 96.77  millions from Rs. 107.72 millions.Operating profit surged to 232.36 millions from the corresponding previous quarter of 174.96 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1050.76 768.33 36.76 2942.93 2338.44 25.85 3175.00 2903.24 9.36
Other Income 20.46 16.84 21.50 183.05 44.08 315.27 115.73 66.72 73.46
PBIDT 232.36 174.96 32.81 738.72 487.29 51.60 708.66 624.85 13.41
Interest 33.57 16.72 100.78 78.56 45.94 71.01 70.20 42.87 63.75
PBDT 198.79 158.24 25.63 660.16 441.35 49.58 638.46 581.98 9.70
Depreciation 39.58 20.62 91.95 89.81 59.86 50.03 87.09 66.21 31.54
PBT 159.21 137.62 15.69 570.35 381.49 49.51 551.37 515.77 6.90
TAX 62.44 29.90 108.83 163.47 88.63 84.44 141.23 100.18 40.98
Deferred Tax 32.13 3.42 839.47 71.89 15.48 364.41 32.08 -2.06 -1657.28
PAT 96.77 107.72 -10.17 406.88 292.86 38.93 410.14 415.59 -1.31
Equity 333.44 323.48 3.08 333.45 323.48 3.08 328.20 307.43 6.76
PBIDTM(%) 22.11 22.77 -2.89 25.10 20.84 20.46 22.32 21.52 3.71
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..